Cargando…

A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement

BACKGROUND: The complement system is one of the most potent weapons of innate immunity. It is not only a mechanism for direct protection against invading pathogens but it also interacts with the adaptive immunity to optimize the pathogen-specific humoral and cellular defense cascades in the body. Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yuanyong, Zhang, Chuanfu, Jia, Leili, Wen, Cuirong, Liu, Huihui, Wang, Yong, Sun, Yansong, Huang, Liuyu, Zhou, Yusen, Song, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224960/ https://www.ncbi.nlm.nih.gov/pubmed/19671191 http://dx.doi.org/10.1186/1743-422X-6-123

Ejemplares similares

A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement
por: Jia, Leili, et al.
Publicado: (2010)

A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
por: Zhang, Chuanfu, et al.
Publicado: (2010)

A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor
por: Qiu, Shaofu, et al.
Publicado: (2012)

Complement controls the immune synapse and tumors control complement
por: Herbert, Alan
Publicado: (2020)

Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
por: Spencer, David A., et al.
Publicado: (2022)

Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
por: Rasool, Mahmood, et al.
Publicado: (2014)

Pre-exposure chemoprophylaxis for HIV: It is time
por: Smith, Stephen M
Publicado: (2004)

HIV associated dementia and HIV encephalitis II: Genes on chromosome 22 expressed in individually microdissected Globus pallidus neurons (Preliminary analysis)
por: Shapshak, Paul, et al.
Publicado: (2011)

An alternative methodology for the prediction of adherence to anti HIV treatment
por: Thompson, I Richard, et al.
Publicado: (2009)

Docking study of HIV-1 reverse transcriptase with phytochemicals
por: Seal, Abhik, et al.
Publicado: (2011)

Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls
por: Brawner, Bridgette M., et al.
Publicado: (2013)

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?
por: Slobod, Karen S, et al.
Publicado: (2005)

Interaction of ganoderic acid on HIV related target: molecular docking studies
por: Akbar, Rahmad, et al.
Publicado: (2011)

HIV-1 envelope accessible surface and polarity: clade, blood, and brain
por: Sowmya, Gopichandran, et al.
Publicado: (2011)

Virtual Screening of Indonesian Herbal Database as HIV-1 Protease Inhibitor
por: Yanuar, Arry, et al.
Publicado: (2014)

Alzheimer's disease and HIV associated dementia related genes: I. location and function
por: Shapshak, Paul, et al.
Publicado: (2008)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Comparative analysis of epitope predictions: proposed library of putative vaccine candidates for HIV
por: Gupta, Arun, et al.
Publicado: (2011)

Virus against virus (VIVI): a potential solution against HIV/AIDS
por: Sheikh, Asfandyar, et al.
Publicado: (2014)

Virtual screening of Indonesian herbal database as HIV-1 reverse transcriptase inhibitor
por: Syahdi, Rezi Riadhi, et al.
Publicado: (2012)

Design of inhibitors of the HIV-1 integrase core domain using virtual screening
por: Regon, Preetom, et al.
Publicado: (2014)

Molecular characterization of full-length Tat in HIV-1 subtypes B and C
por: Roy, Chandra Nath, et al.
Publicado: (2015)

Pattern of the evolution of HIV-1 enν gene in Côte d׳Ivoire
por: Bi, Sery Gonedelé, et al.
Publicado: (2014)

HIV reverse transcriptase: Structural interpretation of drug resistant genetic variants from India
por: Kandathil, Abraham Joseph, et al.
Publicado: (2009)

RNA silencing and HIV: A hypothesis for the etiology of the severe combined immunodeficiency induced by the virus
por: Ludwig, Linda B
Publicado: (2008)

Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
por: Christdas, Johnson, et al.
Publicado: (2015)

Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy
por: Halder, Umesh Chandra
Publicado: (2018)

Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model
por: Jaganatharaja, Janani, et al.
Publicado: (2006)

Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities
por: Shankar, Esaki Muthu, et al.
Publicado: (2007)

Modeling of human CCR5 as Target for HIV-I and Virtual Screening with Marine Therapeutic compounds
por: Manikandan, Selvaraj, et al.
Publicado: (2008)

Evaluation of novel Saquinavir analogs for resistance mutation compatibility and potential as an HIV-Protease inhibitor drug
por: Jayaswal, Amit, et al.
Publicado: (2014)

Binding property of HIV p24 and Reverse transcriptase by chalcones from Pongamia pinnata seeds
por: Mathaiyan, Manikannan, et al.
Publicado: (2018)

Paradigm development: Comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (vif)
por: Balaji, Seetharaaman, et al.
Publicado: (2006)

Design of inhibitors using a combinatorial library for HIV-Nef and human SH3 domain interaction
por: Kakkar, Jatin, et al.
Publicado: (2013)

Effect of HIV-1 Subtype C integrase mutations implied using molecular modeling and docking data
por: Sachithanandham, Jaiprasath, et al.
Publicado: (2016)

Inhibition of lysis of sensitised tumour cells in the presence of complement.
por: Hartveit, F.
Publicado: (1965)

Lead expansion and virtual screening of Indinavir derivate HIV-1 protease inhibitors using pharmacophoric - shape similarity scoring function
por: Shityakov, Sergey, et al.
Publicado: (2010)

The evolutionary significance of certain amino acid substitutions and their consequences for HIV-1 immunogenicity toward HLA's A*0201 and B*27
por: Hecht, Luke, et al.
Publicado: (2013)

Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2009)

Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?
por: Shankar, Esaki Muthu, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_t9e3rnh431sm16btev62rrdmd2